{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T11:27:46Z","timestamp":1794396466481,"version":"4.9.0"},"reference-count":170,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG059501"],"award-info":[{"award-number":["R01AG059501"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.metabol.2025.156432","type":"journal-article","created":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T05:47:39Z","timestamp":1763185659000},"page":"156432","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["HDL dysfunction: a role in the pathogenesis of cardiometabolic syndrome in chronic HIV infection?"],"prefix":"10.1016","volume":"175","author":[{"given":"Konstantinos","family":"Markakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila Fotooh","family":"Abadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud Kombe","family":"Kombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martinos","family":"Christodoulides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodoros","family":"Kelesidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2025.156432_bb0005","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1210\/jc.2006-2190","article-title":"Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease","volume":"92","author":"Triant","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2025.156432_bb0010","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1001\/jamainternmed.2013.3728","article-title":"HIV infection and the risk of acute myocardial infarction","volume":"173","author":"Freiberg","year":"2013","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.metabol.2025.156432_bb0015","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1468-1293.2012.00996.x","article-title":"Relative risk of cardiovascular disease among people living with HIV: a systematic review and meta-analysis","volume":"13","author":"Islam","year":"2012","journal-title":"HIV Med"},{"key":"10.1016\/j.metabol.2025.156432_bb0020","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/nrcardio.2014.167","article-title":"Risk of coronary heart disease in patients with HIV infection","volume":"11","author":"Zanni","year":"2014","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.metabol.2025.156432_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0040365","article-title":"Human immunodeficiency virus impairs reverse cholesterol transport from macrophages","volume":"4","author":"Mujawar","year":"2006","journal-title":"PLoS Biol"},{"key":"10.1016\/j.metabol.2025.156432_bb0030","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1161\/CIRCULATIONAHA.107.189624","article-title":"Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy","volume":"118","author":"Currier","year":"2008","journal-title":"Circulation"},{"issue":"Suppl. 3","key":"10.1016\/j.metabol.2025.156432_bb0035","doi-asserted-by":"crossref","first-page":"S375","DOI":"10.1093\/infdis\/jis200","article-title":"Immunologic basis of cardiovascular disease in HIV-infected adults","volume":"205","author":"Hsue","year":"2012","journal-title":"J Infect Dis"},{"issue":"Suppl. 3","key":"10.1016\/j.metabol.2025.156432_bb0040","doi-asserted-by":"crossref","first-page":"S383","DOI":"10.1093\/infdis\/jis205","article-title":"Body composition and metabolic changes in HIV-infected patients","volume":"205","author":"Stanley","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.metabol.2025.156432_bb0045","first-page":"1045","article-title":"Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome","volume":"74","author":"Grunfeld","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2025.156432_bb0050","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1001\/jama.289.22.2978","article-title":"Impact of HIV infection and HAART on serum lipids in men","volume":"289","author":"Riddler","year":"2003","journal-title":"Jama"},{"key":"10.1016\/j.metabol.2025.156432_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151911","article-title":"Anti-retroviral therapy increases the prevalence of dyslipidemia in south African HIV-infected patients","volume":"11","author":"Dave","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.metabol.2025.156432_bb0060","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nrcardio.2010.222","article-title":"HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms","volume":"8","author":"Navab","year":"2011","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.metabol.2025.156432_bb0065","first-page":"321","article-title":"Atheroprotective effects of high-density lipoproteins","volume":"54","author":"Assmann","year":"2003"},{"key":"10.1016\/j.metabol.2025.156432_bb0070","doi-asserted-by":"crossref","first-page":"196","DOI":"10.2174\/138945008783755557","article-title":"Atheroprotective effects of HDL: beyond reverse cholesterol transport","volume":"9","author":"Feig","year":"2008","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.metabol.2025.156432_bb0075","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJMoa064278","article-title":"HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events","volume":"357","author":"Barter","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2025.156432_bb0080","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12944-023-01827-x","article-title":"HDL-cholesterol concentration and its association with coronary artery calcification: a systematic review and meta-analysis","volume":"22","author":"Abedi","year":"2023","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.metabol.2025.156432_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2024.108684","article-title":"HDL-based therapeutics: a promising frontier in combating viral and bacterial infections","volume":"260","author":"Rani","year":"2024","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.metabol.2025.156432_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154351","article-title":"High-density lipoprotein characteristics and coronary artery disease: a Mendelian randomization study","volume":"112","author":"Prats-Uribe","year":"2020","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2025.156432_bb0095","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1056\/NEJMoa1409065","article-title":"HDL cholesterol efflux capacity and incident cardiovascular events","volume":"371","author":"Rohatgi","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2025.156432_bb0100","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.034763","article-title":"High-density lipoprotein particle concentration and size predict incident coronary artery disease events in a cohort with type 1 diabetes","volume":"13","author":"Costacou","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.metabol.2025.156432_bb0105","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2025.156432_bb0110","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/ni.2784","article-title":"High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3","volume":"15","author":"De Nardo","year":"2014","journal-title":"Nat Immunol"},{"key":"10.1016\/j.metabol.2025.156432_bb0115","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1194\/jlr.R400001-JLR200","article-title":"The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL","volume":"45","author":"Navab","year":"2004","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2025.156432_bb0120","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1056\/NEJMoa043175","article-title":"Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease","volume":"353","author":"Tsimikas","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2025.156432_bb0125","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1161\/01.RES.0000225982.01988.93","article-title":"Endothelial and antithrombotic actions of HDL","volume":"98","author":"Mineo","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.metabol.2025.156432_bb0130","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0021-9150(79)90166-7","article-title":"LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture","volume":"32","author":"Hessler","year":"1979","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2025.156432_bb0135","doi-asserted-by":"crossref","first-page":"15093","DOI":"10.1073\/pnas.0704602104","article-title":"High-density lipoprotein protects macrophages from oxidized low-density lipoprotein-induced apoptosis by promoting efflux of 7-ketocholesterol via ABCG1","volume":"104","author":"Terasaka","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2025.156432_bb0140","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s10557-018-06846-w","article-title":"High-density lipoprotein function and dysfunction in health and disease","volume":"33","author":"Chiesa","year":"2019","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.metabol.2025.156432_bb0145","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1194\/jlr.R300019-JLR200","article-title":"Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host","volume":"45","author":"Khovidhunkit","year":"2004","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2025.156432_bb0150","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1194\/jlr.M059089","article-title":"Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity [S]","volume":"56","author":"Vaisar","year":"2015","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2025.156432_bb0155","first-page":"3007","article-title":"Serum amyloid A: high-density lipoproteins interaction and cardiovascular risk","volume":"36","author":"Zewinger","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.metabol.2025.156432_bb0160","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.tcm.2005.06.004","article-title":"Formation of dysfunctional high-density lipoprotein by myeloperoxidase","volume":"15","author":"Nicholls","year":"2005","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.metabol.2025.156432_bb0165","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1161\/01.RES.0000146094.59640.13","article-title":"Antiinflammatory properties of HDL","volume":"95","author":"Barter","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.metabol.2025.156432_bb0170","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/cvr\/cvu150","article-title":"HDL in innate and adaptive immunity","volume":"103","author":"Catapano","year":"2014","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.metabol.2025.156432_bb0175","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.bbrc.2005.10.065","article-title":"Apolipoprotein A-I induces IL-10 and PGE2 production in human monocytes and inhibits dendritic cell differentiation and maturation","volume":"338","author":"Kim","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.metabol.2025.156432_bb0180","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1161\/ATVBAHA.111.226258","article-title":"Neutrophil activation is attenuated by high-density lipoprotein and apolipoprotein A-I in in vitro and in vivo models of inflammation","volume":"31","author":"Murphy","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metabol.2025.156432_bb0185","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/all.14022","article-title":"Apolipoprotein A-IV acts as an endogenous anti-inflammatory protein and is reduced in treatment-naive allergic patients and allergen-challenged mice","volume":"75","author":"Roula","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.metabol.2025.156432_bb0190","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1172\/JCI115504","article-title":"The terminal complement proteins C5b-9 augment binding of high density lipoprotein and its apolipoproteins A-I and A-II to human endothelial cells","volume":"88","author":"Hamilton","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2025.156432_bb0195","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1097\/01.CCM.0000059724.08290.51","article-title":"Lipoprotein metabolism in patients with severe sepsis","volume":"31","author":"van Leeuwen","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1016\/j.metabol.2025.156432_bb0200","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3389\/fphar.2015.00244","article-title":"HDL in sepsis - risk factor and therapeutic approach","volume":"6","author":"Morin","year":"2015","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.metabol.2025.156432_bb0205","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.clinbiochem.2006.01.015","article-title":"Serum HDL-C levels, log (TG\/HDL-C) values and serum total cholesterol\/HDL-C ratios significantly correlate with radiological extent of disease in patients with community-acquired pneumonia","volume":"39","author":"Deniz","year":"2006","journal-title":"Clin Biochem"},{"key":"10.1016\/j.metabol.2025.156432_bb0210","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.clinbiochem.2006.10.015","article-title":"Serum total cholesterol, HDL-C and LDL-C concentrations significantly correlate with the radiological extent of disease and the degree of smear positivity in patients with pulmonary tuberculosis","volume":"40","author":"Deniz","year":"2007","journal-title":"Clin Biochem"},{"key":"10.1016\/j.metabol.2025.156432_bb0215","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1194\/jlr.P084277","article-title":"Lipid levels are inversely associated with infectious and all-cause mortality: international MONDO study results","volume":"59","author":"Kaysen","year":"2018","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2025.156432_bb0220","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.862999","article-title":"Association of lipid levels with COVID-19 infection, disease severity and mortality: a systematic review and meta-analysis","volume":"9","author":"Chidambaram","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.metabol.2025.156432_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2023.101751","article-title":"The bidirectional interaction of COVID-19 infections and lipoproteins","volume":"37","author":"Feingold","year":"2023","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2025.156432_bb0230","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12155068","article-title":"Association between lipid levels, anti-SARS-CoV-2 spike antibodies and COVID-19 mortality: a prospective cohort study","volume":"12","author":"Mink","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.metabol.2025.156432_bb0235","first-page":"12","article-title":"The association of the levels of high-density lipoprotein and apolipoprotein A1 with SARS-CoV-2 infection and COVID-19 severity: an analysis of the N3C database","author":"Li","year":"2023","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.metabol.2025.156432_bb0240","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1093\/eurheartj\/ehx665","article-title":"U-shaped relationship of HDL and risk of infectious disease: two prospective population-based cohort studies","volume":"39","author":"Madsen","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.metabol.2025.156432_bb0245","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1161\/ATVBAHA.119.313381","article-title":"Causal inference for genetically determined levels of high-density lipoprotein cholesterol and risk of infectious disease","volume":"40","author":"Trinder","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metabol.2025.156432_bb0250","article-title":"Causal association of lipoprotein-associated phospholipids on the risk of sepsis: a Mendelian randomization study","volume":"14","author":"Zeng","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.metabol.2025.156432_bb0255","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/MOL.0b013e328338472d","article-title":"High-density lipoprotein heterogeneity and function in reverse cholesterol transport","volume":"21","author":"Rothblat","year":"2010","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.metabol.2025.156432_bb0260","series-title":"High density lipoproteins: from biological understanding to clinical exploitation","first-page":"3","article-title":"Structure of HDL: particle subclasses and molecular components","author":"Kontush","year":"2015"},{"key":"10.1016\/j.metabol.2025.156432_bb0265","article-title":"The HDL Proteome Watch: compilation of studies leads to new insights on HDL function","volume":"1867","author":"Davidson","year":"2022","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"10.1016\/j.metabol.2025.156432_bb0270","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/MOL.0000000000000374","article-title":"Unbiased and targeted mass spectrometry for the HDL proteome","volume":"28","author":"Singh","year":"2017","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.metabol.2025.156432_bb0275","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1194\/jlr.R035725","article-title":"Proteomic diversity of high density lipoproteins: our emerging understanding of its importance in lipid transport and beyond","volume":"54","author":"Shah","year":"2013","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2025.156432_bb0280","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.atherosclerosis.2015.08.036","article-title":"HIV infection induces structural and functional changes in high density lipoproteins","volume":"243","author":"Siegel","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2025.156432_bb0285","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1590\/S0036-46652008000400007","article-title":"Alterations in lipid transfer to high-density lipoprotein (HDL) and activity of paraoxonase-1 in HIV+ patients","volume":"50","author":"Daminelli","year":"2008","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"10.1016\/j.metabol.2025.156432_bb0290","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1194\/jlr.P018457","article-title":"Serum paraoxonase-3 concentration in HIV-infected patients. Evidence for a protective role against oxidation","volume":"53","author":"Aragon\u00e8s","year":"2012","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2025.156432_bb0295","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2024.1343361","article-title":"People living with HIV display increased anti-apolipoprotein A1 auto-antibodies, inflammation, and kynurenine metabolites: a case-control study","volume":"11","author":"Frias","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.metabol.2025.156432_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2024.118355","article-title":"Associations between high-density lipoprotein particle\u2019s proteome, subfractions and autoantibodies against apolipoprotein A1 in HIV patients","volume":"395","author":"Frias","year":"2024","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2025.156432_bb0305","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehab724.2906","article-title":"HIV-infected patients display increased proatherogenic anti-apolipoprotein A1 autoantibodies, inflammatory and metabolomic markers","volume":"42","author":"Frias","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.metabol.2025.156432_bb0310","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1089\/aid.2014.0239","article-title":"Characterization of lipid composition and high-density lipoprotein function in HIV-infected individuals on stable antiretroviral regimens","volume":"31","author":"Munger","year":"2015","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.metabol.2025.156432_bb0315","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1515\/CCLM.2010.218","article-title":"Human immunodeficiency virus-infection induces major changes in high-density lipoprotein particle size distribution and composition: the effect of antiretroviral treatment and disease severity","volume":"48","author":"Aragon\u00e8s","year":"2010","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.metabol.2025.156432_bb0320","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1161\/ATVBAHA.113.301538","article-title":"Impaired lipoprotein processing in HIV patients on antiretroviral therapy: aberrant high-density lipoprotein lipids, stability, and function","volume":"33","author":"Gillard","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metabol.2025.156432_bb0325","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1476-511X-10-35","article-title":"HIV-1 infected patients with suppressed plasma viremia on treatment have pro-inflammatory HDL","volume":"10","author":"Kelesidis","year":"2011","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.metabol.2025.156432_bb0330","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1194\/jlr.D018937","article-title":"A biochemical fluorometric method for assessing the oxidative properties of HDL","volume":"52","author":"Kelesidis","year":"2011","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2025.156432_bb0335","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1172\/JCI115532","article-title":"Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein","volume":"88","author":"Navab","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2025.156432_bb0340","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111716","article-title":"A high throughput biochemical fluorometric method for measuring lipid peroxidation in HDL","volume":"9","author":"Kelesidis","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.metabol.2025.156432_bb0345","doi-asserted-by":"crossref","DOI":"10.1186\/1476-511X-12-23","article-title":"Dysfunctional HDL and progression of atherosclerosis in HIV-1-infected and -uninfected adults","volume":"12","author":"Kelesidis","year":"2013","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.metabol.2025.156432_bb0350","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3851\/IMP3093","article-title":"Changes in plasma levels of oxidized lipoproteins and lipoprotein subfractions with atazanavir-, raltegravir-, darunavir-based initial antiviral therapy and associations with common carotid artery intima-media thickness: ACTG 5260s","volume":"22","author":"Kelesidis","year":"2017","journal-title":"Antivir Ther"},{"key":"10.1016\/j.metabol.2025.156432_bb0355","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3851\/IMP2756","article-title":"HDL redox activity is increased in HIV-infected men in association with macrophage activation and non-calcified coronary atherosclerotic plaque","volume":"19","author":"Zanni","year":"2014","journal-title":"Antivir Ther"},{"key":"10.1016\/j.metabol.2025.156432_bb0360","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/QAI.0000000000001383","article-title":"Predictors of impaired HDL function in HIV-1 infected compared to uninfected individuals","volume":"75","author":"Kelesidis","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.metabol.2025.156432_bb0365","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1097\/QAD.0000000000001238","article-title":"Oxidized lipoproteins are associated with markers of inflammation and immune activation in HIV-1 infection","volume":"30","author":"Kelesidis","year":"2016","journal-title":"AIDS"},{"key":"10.1016\/j.metabol.2025.156432_bb0370","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000010955","article-title":"Soluble levels of receptor for advanced glycation endproducts and dysfunctional high-density lipoprotein in persons infected with human immunodeficiency virus: ACTG NWCS332","volume":"97","author":"Kelesidis","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.metabol.2025.156432_bb0375","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1097\/QAD.0000000000001642","article-title":"Dysfunctional high-density lipoprotein from HIV+ individuals promotes monocyte-derived foam cell formation in vitro","volume":"31","author":"Angelovich","year":"2017","journal-title":"AIDS"},{"key":"10.1016\/j.metabol.2025.156432_bb0380","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.atherosclerosis.2007.10.018","article-title":"HIV infection and high density lipoprotein metabolism","volume":"199","author":"Rose","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2025.156432_bb0385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/QAD.0000000000002385","article-title":"Comorbidities of HIV infection: role of Nef-induced impairment of cholesterol metabolism and lipid raft functionality","volume":"34","author":"Sviridov","year":"2020","journal-title":"Aids"},{"key":"10.1016\/j.metabol.2025.156432_bb0390","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12977-015-0188-y","article-title":"HIV inhibits endothelial reverse cholesterol transport through impacting subcellular Caveolin-1 trafficking","volume":"12","author":"Lin","year":"2015","journal-title":"Retrovirology"},{"key":"10.1016\/j.metabol.2025.156432_bb0395","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.atherosclerosis.2015.10.103","article-title":"Lipid metabolism in patients infected with Nef-deficient HIV-1 strain","volume":"244","author":"Low","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2025.156432_bb0400","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofu108","article-title":"High-density lipoprotein-mediated cholesterol efflux capacity is improved by treatment with antiretroviral therapy in acute human immunodeficiency virus infection","volume":"1","author":"Lo","year":"2014","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.metabol.2025.156432_bb0405","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1096\/fj.13-246876","article-title":"HIV protein Nef causes dyslipidemia and formation of foam cells in mouse models of atherosclerosis","volume":"28","author":"Cui","year":"2014","journal-title":"FASEB J"},{"key":"10.1016\/j.metabol.2025.156432_bb0410","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1194\/jlr.M023119","article-title":"HIV-1 Nef mobilizes lipid rafts in macrophages through a pathway that competes with ABCA1-dependent cholesterol efflux","volume":"53","author":"Cui","year":"2012","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2025.156432_bb0415","doi-asserted-by":"crossref","first-page":"28870","DOI":"10.1074\/jbc.M114.583591","article-title":"HIV-1 protein Nef inhibits activity of ATP-binding cassette transporter A1 by targeting endoplasmic reticulum chaperone calnexin","volume":"289","author":"Jennelle","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2025.156432_bb0420","doi-asserted-by":"crossref","DOI":"10.3390\/cells10010174","article-title":"The impact of HIV- and ART-induced mitochondrial dysfunction in cellular senescence and aging","volume":"10","author":"Schank","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.metabol.2025.156432_bb0425","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/1476-511X-11-169","article-title":"Mitochondrial function is involved in regulation of cholesterol efflux to apolipoprotein (apo)A-I from murine RAW 264.7 macrophages","volume":"11","author":"Allen","year":"2012","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.metabol.2025.156432_bb0430","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.atherosclerosis.2008.09.006","article-title":"Overexpression of mitochondrial cholesterol delivery protein, StAR, decreases intracellular lipids and inflammatory factors secretion in macrophages","volume":"204","author":"Ning","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2025.156432_bb0435","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/cvr\/cvq015","article-title":"Overexpression of steroidogenic acute regulatory protein increases macrophage cholesterol efflux to apolipoprotein AI","volume":"86","author":"Taylor","year":"2010","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.metabol.2025.156432_bb0440","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1042\/CS20140047","article-title":"Targeting mitochondrial 18 kDa translocator protein (TSPO) regulates macrophage cholesterol efflux and lipid phenotype","volume":"127","author":"Taylor","year":"2014","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.metabol.2025.156432_bb0445","first-page":"249","article-title":"Lipid abnormalities in persons living with HIV infection","volume":"35","author":"Waters","year":"2019","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.metabol.2025.156432_bb0450","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1468-1293.2007.00470.x","article-title":"Longitudinal changes in serum lipids among HIV-infected men on highly active antiretroviral therapy","volume":"8","author":"Riddler","year":"2007","journal-title":"HIV Med"},{"key":"10.1016\/j.metabol.2025.156432_bb0455","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1210\/jc.2017-01334","article-title":"HDL cholesterol efflux capacity in newly diagnosed HIV and effects of antiretroviral therapy","volume":"102","author":"Toribio","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2025.156432_bb0460","doi-asserted-by":"crossref","first-page":"304","DOI":"10.2353\/ajpath.2007.060965","article-title":"Human immunodeficiency virus protease inhibitor ritonavir inhibits cholesterol efflux from human macrophage-derived foam cells","volume":"171","author":"Wang","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.metabol.2025.156432_bb0465","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1310\/7381-M1YD-RTV5-4RYT","article-title":"Concentration of circulating oxidized LDL in HIV-infected patients treated with antiretroviral agents: relation to HIV-related lipodystrophy","volume":"7","author":"Duong","year":"2006","journal-title":"HIV Clin Trials"},{"key":"10.1016\/j.metabol.2025.156432_bb0470","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/QAI.0000000000000566","article-title":"Oxidized LDL levels are increased in HIV infection and may drive monocyte activation","volume":"69","author":"Zidar","year":"2015","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.metabol.2025.156432_bb0475","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/QAD.0000000000000885","article-title":"Changes in oxidized lipids drive the improvement in monocyte activation and vascular disease after statin therapy in HIV","volume":"30","author":"Hileman","year":"2016","journal-title":"AIDS (London, England)"},{"key":"10.1016\/j.metabol.2025.156432_bb0480","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1161\/CIRCULATIONAHA.118.036232","article-title":"Senescent phenotype induced by p90RSK-NRF2 signaling sensitizes monocytes and macrophages to oxidative stress in HIV-positive individuals","volume":"139","author":"Singh","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2025.156432_bb0485","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.atherosclerosis.2014.12.005","article-title":"Lipoprotein concentration, particle number, size and cholesterol efflux capacity are associated with mitochondrial oxidative stress and function in an HIV positive cohort","volume":"239","author":"Parikh","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2025.156432_bb0490","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01755-20","article-title":"In vitro exposure of leukocytes to HIV preexposure prophylaxis decreases mitochondrial function and alters gene expression profiles","volume":"65","author":"Bowman","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.metabol.2025.156432_bb0495","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/QAI.0b013e31817bbbf0","article-title":"Antiretroviral therapy is associated with an atherogenic lipoprotein phenotype among HIV-1-infected men in the Multicenter AIDS Cohort Study","volume":"48","author":"Riddler","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.metabol.2025.156432_bb0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2021.06.370","article-title":"High-density lipoprotein (HDL) subclasses and functionality in HIV patients","volume":"331","author":"Hudson","year":"2021","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2025.156432_bb0505","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1161\/ATVBAHA.117.307025","article-title":"From high-density lipoprotein cholesterol to measurements of function: prospects for the development of tests for high-density lipoprotein functionality in cardiovascular disease","volume":"38","author":"Sacks","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metabol.2025.156432_bb0510","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/978-3-319-09665-0_2","article-title":"HDL biogenesis, remodeling, and catabolism","volume":"224","author":"Zannis","year":"2015","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.metabol.2025.156432_bb0515","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.atherosclerosis.2020.04.015","article-title":"High density lipoprotein functionality and cardiovascular events and mortality: a systematic review and meta-analysis","volume":"302","author":"Soria-Florido","year":"2020","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2025.156432_bb0520","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3389\/fcvm.2020.00039","article-title":"High density lipoproteins: metabolism, function, and therapeutic potential","volume":"7","author":"Jomard","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.metabol.2025.156432_bb0525","doi-asserted-by":"crossref","DOI":"10.1126\/science.abe6729","article-title":"Enterically derived high-density lipoprotein restrains liver injury through the portal vein","volume":"373","author":"Han","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.metabol.2025.156432_bb0530","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.atherosclerosis.2009.05.001","article-title":"Lipoprotein particle subclasses, cardiovascular disease and HIV infection","volume":"207","author":"Duprez","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2025.156432_bb0535","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1002\/art.21976","article-title":"Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis","volume":"54","author":"McMahon","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"Suppl","key":"10.1016\/j.metabol.2025.156432_bb0540","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.1194\/jlr.R800036-JLR200","article-title":"The role of dysfunctional HDL in atherosclerosis","volume":"50","author":"Navab","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2025.156432_bb0545","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1086\/649560","article-title":"High-density lipoprotein particles and markers of inflammation and thrombotic activity in patients with untreated HIV infection","volume":"201","author":"Baker","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.metabol.2025.156432_bb0550","article-title":"Greater IL-6, D-dimer, and ICAM-1 levels are associated with lower small HDL particle concentration in the multicenter AIDS cohort study","volume":"6","author":"Sarkar","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.metabol.2025.156432_bb0555","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/01.aids.0000163936.99401.fe","article-title":"Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort","volume":"19","author":"Konopnicki","year":"2005","journal-title":"Aids"},{"key":"10.1016\/j.metabol.2025.156432_bb0560","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S1473-3099(05)70216-4","article-title":"Global epidemiology of hepatitis C virus infection","volume":"5","author":"Shepard","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.metabol.2025.156432_bb0565","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/QCO.0b013e32834ef599","article-title":"From nonalcoholic fatty liver to nonalcoholic steatohepatitis and cirrhosis in HIV-infected patients: diagnosis and management","volume":"25","author":"Lemoine","year":"2012","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.metabol.2025.156432_bb0570","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2017-000166","article-title":"Mechanisms of liver disease in patients infected with HIV","volume":"4","author":"Kaspar","year":"2017","journal-title":"BMJ Open Gastroenterol"},{"key":"10.1016\/j.metabol.2025.156432_bb0575","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1086\/652749","article-title":"Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection","volume":"201","author":"Neuhaus","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.metabol.2025.156432_bb0580","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/jama.2012.6698","article-title":"Arterial inflammation in patients with HIV","volume":"308","author":"Subramanian","year":"2012","journal-title":"Jama"},{"key":"10.1016\/j.metabol.2025.156432_bb0585","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1093\/infdis\/jir520","article-title":"Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients","volume":"204","author":"Burdo","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.metabol.2025.156432_bb0590","first-page":"1149","article-title":"Decreased plasma concentrations of HDL cholesterol in HIV-infected individuals are associated with immune activation","volume":"7","author":"Zangerle","year":"1994"},{"key":"10.1016\/j.metabol.2025.156432_bb0595","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1089\/ars.2007.1670","article-title":"Oxidative stress, lipid rafts, and macrophage reprogramming","volume":"9","author":"Cuschieri","year":"2007","journal-title":"Antioxid Redox Signal"},{"issue":"776","key":"10.1016\/j.metabol.2025.156432_bb0600","first-page":"1","article-title":"Modulation of pro-oxidant and pro-inflammatory activities of M1 macrophages by the natural dipeptide carnosine","volume":"21","author":"Fresta","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.metabol.2025.156432_bb0605","doi-asserted-by":"crossref","first-page":"5989","DOI":"10.1128\/MCB.00541-09","article-title":"An innate immunity signaling process suppresses macrophage ABCA1 expression through IRAK-1-mediated downregulation of retinoic acid receptor alpha and NFATc2","volume":"29","author":"Maitra","year":"2009","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.metabol.2025.156432_bb0610","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003285","article-title":"Antiretroviral therapy normalizes autoantibody profile of HIV patients by decreasing CD33+CD11b+HLA-DR+ cells: a cross-sectional study","volume":"95","author":"Meng","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.metabol.2025.156432_bb0615","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s12026-015-8767-5","article-title":"Autoimmunity and dysmetabolism of human acquired immunodeficiency syndrome","volume":"64","author":"Huang","year":"2016","journal-title":"Immunol Res"},{"key":"10.1016\/j.metabol.2025.156432_bb0620","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1097\/RHU.0000000000002028","article-title":"HIV-associated rheumatic diseases: a narrative review","volume":"30","author":"Akram","year":"2024","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.metabol.2025.156432_bb0625","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s12072-018-9842-5","article-title":"Autoantibody to apolipoprotein A-1 in hepatitis C virus infection: a role in atherosclerosis?","volume":"12","author":"Bridge","year":"2018","journal-title":"Hepatol Int"},{"key":"10.1016\/j.metabol.2025.156432_bb0630","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13818","article-title":"Autoantibodies against apolipoprotein A-1 after COVID-19 predict symptoms persistence","volume":"52","author":"L\u2019Huillier","year":"2022","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.metabol.2025.156432_bb0635","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13661","article-title":"SARS-CoV-2 infection as a trigger of humoral response against apolipoprotein A-1","volume":"51","author":"Pagano","year":"2021","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.metabol.2025.156432_bb0640","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jinf.2017.11.008","article-title":"Anti-apolipoprotein A-1 autoantibodies are associated with immunodeficiency and systemic inflammation in HIV patients","volume":"76","author":"Satta","year":"2018","journal-title":"J Infect"},{"key":"10.1016\/j.metabol.2025.156432_bb0645","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/eurheartj\/ehq521","article-title":"Anti-Apolipoprotein A-1 auto-antibodies are active mediators of atherosclerotic plaque vulnerability","volume":"32","author":"Montecucco","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.metabol.2025.156432_bb0650","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1160\/TH14-12-1039","article-title":"Anti-apoA-1 auto-antibodies increase mouse atherosclerotic plaque vulnerability, myocardial necrosis and mortality triggering TLR2 and TLR4","volume":"114","author":"Montecucco","year":"2015","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.metabol.2025.156432_bb0655","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/rheumatology\/ken397","article-title":"Anti-atherogenic and anti-inflammatory properties of high-density lipoprotein are affected by specific antibodies in systemic lupus erythematosus","volume":"48","author":"Batuca","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.metabol.2025.156432_bb0660","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1111\/bcp.13198","article-title":"Extended-release niacin increases anti-apolipoprotein A-I antibodies that block the antioxidant effect of high-density lipoprotein-cholesterol: the EXPLORE clinical trial","volume":"83","author":"Batuca","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.metabol.2025.156432_bb0665","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20030732","article-title":"Antibodies against the C-terminus of ApoA-1 are inversely associated with cholesterol efflux capacity and HDL metabolism in subjects with and without type 2 diabetes mellitus","volume":"20","author":"Dullaart","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.metabol.2025.156432_bb0670","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s001250050049","article-title":"Glycation impairs high-density lipoprotein function","volume":"43","author":"Hedrick","year":"2000","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2025.156432_bb0675","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.2337\/db11-0291","article-title":"Total soluble and endogenous secretory receptor for advanced glycation end products as predictive biomarkers of coronary heart disease risk in patients with type 2 diabetes: an analysis from the CARDS trial","volume":"60","author":"Colhoun","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2025.156432_bb0680","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1189\/jlb.71.6.1012","article-title":"Oxidized low-density and high-density lipoproteins regulate the production of matrix metalloproteinase-1 and -9 by activated monocytes","volume":"71","author":"Ardans","year":"2002","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.metabol.2025.156432_bb0685","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1007\/s10753-016-0367-6","article-title":"Soluble levels of receptor for advanced glycation endproducts (RAGE) and progression of atherosclerosis in individuals infected with human immunodeficiency virus: ACTG NWCS 332","volume":"39","author":"Danoff","year":"2016","journal-title":"Inflammation"},{"key":"10.1016\/j.metabol.2025.156432_bb0690","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/ijo.2016.190","article-title":"Weight loss surgery in adolescents corrects high-density lipoprotein subspecies and their function","volume":"41","author":"Davidson","year":"2017","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.metabol.2025.156432_bb0695","doi-asserted-by":"crossref","first-page":"e343","DOI":"10.1093\/eurjpc\/zwac068","article-title":"Levels of high-density lipoprotein lipid peroxidation according to spatial socioeconomic deprivation and rurality among patients with coronary artery disease","volume":"29","author":"Jaehn","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.metabol.2025.156432_bb0700","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1177\/2047487319848199","article-title":"The impact of aerobic and isometric exercise on different measures of dysfunctional high-density lipoprotein in patients with hypertension","volume":"26","author":"Pagonas","year":"2019","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.metabol.2025.156432_bb0705","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nrcardio.2015.169","article-title":"Regulatory T cells in cardiovascular diseases","volume":"13","author":"Meng","year":"2016","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.metabol.2025.156432_bb0710","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1093\/infdis\/jis235","article-title":"Early and long-lasting alteration of effector CD45RA(\u2212)Foxp3(high) regulatory T-cell homeostasis during HIV infection","volume":"205","author":"Simonetta","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.metabol.2025.156432_bb0715","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1146624","article-title":"Impaired response of memory Treg to high density lipoproteins is associated with intermediate\/high cardiovascular disease risk in persons with HIV","volume":"14","author":"Atehortua","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.metabol.2025.156432_bb0720","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.atherosclerosis.2006.07.024","article-title":"Serum paraoxonase-1 activity and concentration are influenced by human immunodeficiency virus infection","volume":"194","author":"Parra","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2025.156432_bb0725","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1089\/aid.2013.0010","article-title":"Short communication: paraoxonase 1 (PON1) in French HIV-infected patients under antiretroviral therapy: relationship with the metabolic syndrome and inflammation","volume":"29","author":"Bobin-Dubigeon","year":"2013","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.metabol.2025.156432_bb0730","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010160","article-title":"ApoA-I mimetics reduce systemic and gut inflammation in chronic treated HIV","volume":"18","author":"Daskou","year":"2022","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.metabol.2025.156432_bb0735","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/QAD.0000000000002785","article-title":"Apolipoprotein A-I mimetics attenuate macrophage activation in chronic treated HIV","volume":"35","author":"Mu","year":"2021","journal-title":"AIDS"},{"key":"10.1016\/j.metabol.2025.156432_bb0740","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154888","article-title":"ApoA-I mimetics favorably impact cyclooxygenase 2 and bioactive lipids that may contribute to cardiometabolic syndrome in chronic treated HIV","volume":"124","author":"Daskou","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2025.156432_bb0745","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.atherosclerosis.2013.04.010","article-title":"The effect of HIV infection on atherosclerosis and lipoprotein metabolism: a one year prospective study","volume":"229","author":"Rose","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2025.156432_bb0750","doi-asserted-by":"crossref","first-page":"16168","DOI":"10.1002\/jcp.28276","article-title":"High-density lipoprotein lipid peroxidation as a molecular signature of the risk for developing cardiovascular disease: results from MASHAD cohort","volume":"234","author":"Samadi","year":"2019","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.metabol.2025.156432_bb0755","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1080\/07853890.2022.2063374","article-title":"Predictive value of HDL function in patients with coronary artery disease: relationship with coronary plaque characteristics and clinical events","volume":"54","author":"Magnoni","year":"2022","journal-title":"Ann Med"},{"key":"10.1016\/j.metabol.2025.156432_bb0760","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1089\/jir.2019.0029","article-title":"High-density lipoproteins decrease proinflammatory activity and modulate the innate immune response","volume":"39","author":"Taborda","year":"2019","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.metabol.2025.156432_bb0765","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3389\/fcvm.2020.00095","article-title":"NLRP3 inflammasome signaling as a link between HIV-1 infection and atherosclerotic cardiovascular disease","volume":"7","author":"Mullis","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.metabol.2025.156432_bb0770","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41598-021-04308-2","article-title":"Increased prevalence of clonal hematopoiesis of indeterminate potential amongst people living with HIV","volume":"12","author":"Bick","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.metabol.2025.156432_bb0775","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.atherosclerosis.2013.10.018","article-title":"CER-001, a HDL-mimetic, stimulates the reverse lipid transport and atherosclerosis regression in high cholesterol diet-fed LDL-receptor deficient mice","volume":"232","author":"Tardy","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2025.156432_bb0780","first-page":"1076","article-title":"Micro-RNAs and high-density lipoprotein","volume":"36","author":"Canfr\u00e1n-Duque","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2025.156432_bb0785","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1161\/CIRCRESAHA.114.300645","article-title":"MicroRNA control of high-density lipoprotein metabolism and function","volume":"114","author":"Rayner","year":"2014","journal-title":"Circ Res"},{"issue":"711","key":"10.1016\/j.metabol.2025.156432_bb0790","first-page":"1","article-title":"HDL-based therapy: vascular protection at all stages","volume":"11","author":"Poznyak","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.metabol.2025.156432_bb0795","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.925587","article-title":"Effects of PCSK9 inhibitors on HDL cholesterol efflux and serum cholesterol loading capacity in familial hypercholesterolemia subjects: a multi-lipid-center real-world evaluation","volume":"9","author":"Palumbo","year":"2022","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.metabol.2025.156432_bb0800","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/ATVBAHA.121.317181","article-title":"Pharmacological inhibition of CETP (cholesteryl Ester transfer protein) increases HDL (high-density lipoprotein) that contains ApoC3 and other HDL subspecies associated with higher risk of coronary heart disease","volume":"42","author":"Furtado","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metabol.2025.156432_bb0805","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1056\/NEJMoa2400969","article-title":"Apolipoprotein A1 infusions and cardiovascular outcomes after acute myocardial infarction","volume":"390","author":"Gibson","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2025.156432_bb0810","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.1093\/eurheartj\/ehae614","article-title":"Apolipoprotein A-I infusions and cardiovascular outcomes in acute myocardial infarction according to baseline LDL-cholesterol levels: the AEGIS-II trial","volume":"45","author":"Gibson","year":"2024","journal-title":"Eur Heart J"},{"issue":"Suppl","key":"10.1016\/j.metabol.2025.156432_bb0815","doi-asserted-by":"crossref","first-page":"S423","DOI":"10.1194\/jlr.R800094-JLR200","article-title":"Prostanoids in health and disease","volume":"50","author":"Smyth","year":"2009","journal-title":"J Lipid Res"},{"issue":"3115","key":"10.1016\/j.metabol.2025.156432_bb0820","first-page":"1","article-title":"The dualistic effect of COX-2-mediated signaling in obesity and insulin resistance","volume":"20","author":"Chan","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.metabol.2025.156432_bb0825","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1161\/01.ATV.0000167412.98221.1a","article-title":"D-4F and statins synergize to render HDL antiinflammatory in mice and monkeys and cause lesion regression in old apolipoprotein E-null mice","volume":"25","author":"Navab","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metabol.2025.156432_bb0830","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.metabol.2013.01.020","article-title":"Altered relationship of plasma triglycerides to HDL cholesterol in patients with HIV\/HAART-associated dyslipidemia: further evidence for a unique form of metabolic syndrome in HIV patients","volume":"62","author":"Vu","year":"2013","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2025.156432_bb0835","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/QAD.0b013e32835d0da1","article-title":"Impact of genetic factors on dyslipidemia in HIV-infected patients starting antiretroviral therapy","volume":"27","author":"Egana-Gorrono","year":"2013","journal-title":"AIDS"},{"key":"10.1016\/j.metabol.2025.156432_bb0840","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1089\/aid.2015.0061","article-title":"Polymorphisms in LPL, CETP, and HL protect HIV-infected patients from atherogenic dyslipidemia in an allele-dose-dependent manner","volume":"31","author":"Guardiola","year":"2015","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.metabol.2025.156432_bb0845","doi-asserted-by":"crossref","DOI":"10.7448\/IAS.17.4.19557","article-title":"Polymorphisms in LPL, CETP, and HL protect HIV-infected patients from atherogenic dyslipidemia in an allele-dose-dependent manner","volume":"17","author":"Echeverria","year":"2014","journal-title":"J Int AIDS Soc"},{"key":"10.1016\/j.metabol.2025.156432_bb0850","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/FPC.0b013e32814db8b7","article-title":"Contribution of 20 single nucleotide polymorphisms of 13 genes to dyslipidemia associated with antiretroviral therapy","volume":"17","author":"Arnedo","year":"2007","journal-title":"Pharmacogenet Genomics"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049525003014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049525003014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T20:12:41Z","timestamp":1781122361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049525003014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":170,"alternative-id":["S0026049525003014"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2025.156432","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HDL dysfunction: a role in the pathogenesis of cardiometabolic syndrome in chronic HIV infection?","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2025.156432","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"156432"}}